Clinical trial
Evaluation of Serum Ferroptosis Biomarkers (GPX4 and MDA) and Their Relationship With Disease Stage, Clinical Severity, and Trichoscopic Findings in Patients With Alopecia Areata
NCT07733063 is registered in ClinicalTrials.gov with Istanbul Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Serum Ferroptosis Biomarkers (GPX4 and MDA) and Their Relationship With Disease Stage, Clinical Severity, and Trichoscopic Findings in Patients With Alopecia Areata
- Lead sponsor
- Istanbul Training and Research Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2026
- Completion date
- January 1, 2027
- Enrollment
- 156 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alopecia, alopecia areata, alopecia areata (& ophiasis), alopecia areata(aa)